Dr. Anusha Kalbasi from Stanford discusses the immunotherapy study using IL13Rα2 CAR T cell for the treatment of metastatic solid tumors on March 27, 2024. For more information about this trial, visit α2-car-t-cell-study-for-solid-tumor-cancers. Visit the LACNETS Clinical Trials page for more information at
Hide player controls
Hide resume playing